How to institute the low-FODMAP diet

Journal of Gastroenterology and Hepatology (Australia)

Volumn 32, Issue , 2017, Pages 8-10

  Barrett, Jacqueline S ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

diet; FODMAPs; functional gastrointestinal disorder; irritable bowel syndrome; lactose

Indexed keywords

DISACCHARIDE; MONOSACCHARIDE; OLIGOSACCHARIDE; POLYOL; PREBIOTIC AGENT; CARBOHYDRATE DIET; POLYMER;

CLINICAL RESEARCH; DIET; DIET RESTRICTION; DIETITIAN; DISEASE SEVERITY; FOLLOW UP; GASTROENTEROLOGIST; HEALTH EDUCATION; HUMAN; INTESTINE FLORA; IRRITABLE COLON; MEAL; NUTRITIONAL ASSESSMENT; NUTRITIONAL STATUS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; ADMINISTRATION AND DOSAGE; ADVERSE EFFECTS; CARBOHYDRATE DIET; DIET THERAPY; LOW CARBOHYDRATE DIET; PROCEDURES;

DIET, CARBOHYDRATE-RESTRICTED; DIETARY CARBOHYDRATES; DISACCHARIDES; HUMANS; IRRITABLE BOWEL SYNDROME; MONOSACCHARIDES; OLIGOSACCHARIDES; POLYMERS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 85014044571     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/jgh.13686     Document Type: Review

References (21)

1. Lovell RM, Ford AC. Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis. Clin. Gastroenterol. Hepatol. 2012; 10 (7): 712–210000–.
2. Canavan C, West J, Card T. Review article: the economic impact of the irritable bowel syndrome. Aliment. Pharmacol. Ther. 2014; 40 (9): 1023–1034.
3. Biesiekierski JR, Peters SL, Newnham ED, Rosella O, Muir JG, Gibson PR. No effects of gluten in patients with self-reported non-celiac gluten sensitivity after dietary reduction of fermentable, poorly absorbed, short-chain carbohydrates. Gastroenterology 2013; 145 (2): 320–8 e1-3.
4. Murch S, Jenkins H, Auth M et al. Joint BSPGHAN and coeliac UK guidelines for the diagnosis and management of coeliac disease in children. Arch. Dis. Child. 2013. DOI: 10.1136/archdischild-2013-303996.
5. Rumessen JJ, Gudmand-Hoyer E. Fructans of chicory: intestinal transport and fermentation of different chain lengths and relation to fructose and sorbitol malabsorption. Am. J. Clin. Nutr. 1998; 68 (2): 357–364.
6. Macfarlane GT, Steed H, Macfarlane S. Bacterial metabolism and health-related effects of galacto-oligosaccharides and other prebiotics. J. Appl. Microbiol. 2008; 104 (2): 305–344.
7. Murray K, Wilkinson-Smith V, Hoad C et al. Differential effects of FODMAPs (fermentable oligo-, di-, mono-saccharides and polyols) on small and large intestinal contents in healthy subjects shown by MRI. Am. J. Gastroenterol. 2014; 109 (1): 110–119.
8. Law D, Conklin J, Pimentel M. Lactose intolerance and the role of the lactose breath test. Am. J. Gastroenterol. 2010; 105 (8): 1726–1728.
9. Rosado JL, Solomons NW. Sensitivity and specificity of the hydrogen breath-analysis test for detecting malabsorption of physiological doses of lactose. Clin. Chem. 1983; 29 (3): 545–548.
10. Yao CK, Tan H-L, van Langenberg DR et al. Dietary sorbitol and mannitol: food content and distinct absorption patterns between healthy individuals and patients with irritable bowel syndrome. J. Hum. Nutr. Diet. 2014; 27 (Suppl. 2): 263–275.
11. Halmos EP, Power VA, Shepherd SJ, Gibson PR, Muir JG. A diet low in FODMAPs reduces symptoms of irritable bowel syndrome. Gastroenterology 2014; 146 (1): 67–75.e5
12. Staudacher HM, Whelan K, Irving PM, Lomer MC. Comparison of symptom response following advice for a diet low in fermentable carbohydrates (FODMAPs) versus standard dietary advice in patients with irritable bowel syndrome. J. Hum. Nutr. Diet. 2011; 24 (5): 487–495.
13. Chumpitazi B, Cope J, Hollister E et al. Randomised clinical trial: gut microbiome biomarkers are associated with clinical response to a low FODMAP diet in children with the irritable bowel syndrome. Aliment. Pharmacol. Ther. 2015; 42 (4): 418–427.
14. Shepherd SJ, Gibson PR. Fructose malabsorption and symptoms of irritable bowel syndrome: guidelines for effective dietary management. J. Am. Diet. Assoc. 2006; 106 (10): 1631–1639.
15. Whigham L, Joyce T, Harper G et al. Clinical effectiveness and economic costs of group versus one-to-one education for short-chain fermentable carbohydrate restriction (low FODMAP diet) in the management of irritable bowel syndrome. J. Hum. Nutr. Diet. 2015; 28 (6): 687–696.
16. de Roest RH, Dobbs BR, Chapman BA et al. The low FODMAP diet improves gastrointestinal symptoms in patients with irritable bowel syndrome: a prospective study. Int. J. Clin. Pract. 2013; 67 (9): 895–903.
17. Riegler G, Esposito I. Bristol scale stool form. A still valid help in medical practice and clinical research. Tech. Coloproctol. 2001; 5 (3): 163–164.
18. Staudacher HM, Lomer MCE, Anderson JL et al. Fermentable carbohydrate restriction reduces luminal bifidobacteria and gastrointestinal symptoms in patients with irritable bowel syndrome. J. Nutr. 2012; 142 (8): 1510–1518.
19. Halmos EP, Christophersen CT, Bird AR, Shepherd SJ, Gibson PR, Muir JG. Diets that differ in their FODMAP content alter the colonic luminal microenvironment. Gut 2015; 64 (1): 93–100.
20. Pool-Zobel B, Van Loo J, Rowland I, Roberfroid M. Experimental evidences on the potential of prebiotic fructans to reduce the risk of colon cancer. Br. J. Nutr. 2002; 87 (2): 273–282.
21. Davis LM, Martinez I, Walter J, Hutkins R. A dose dependent impact of prebiotic galactooligosaccharides on the intestinal microbiota of healthy adults. Int. J. Food Microbiol. 2010; 144 (2): 285–292.